LY2801653 dihydrochloride inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis.
Molecular Weight
625.45
Molecular Formula
C30H24Cl2F2N6O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
LY2801653 dihydrochloride similarly targets c-MET and is used in research to explore its potential in oncology therapy.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
